Nonalcoholic Steatohepatitis Treatment Market, Global Outlook and Forecast 2022-2028
Nonalcoholic steatohepatitis is a syndrome causes liver damage develops in the individuals who are not alcoholic. The primary mechanisms of nonalcoholic steatohepatitis are obesity, glucose intolerance, metabolic stress, inflammation, dyslipidemia and fibrosis. Nonalcoholic steatohepatitis can develop into cirrhosis and liver cancer. For the diagnosis of the nonalcoholic steatohepatitis, liver biopsy, imaging procedures and various types of blood tests including complete blood count, fasting blood sugar, liver enzyme tests etc. are required. The common nonalcoholic steatohepatitis treatment may include weight loss, type-2 diabetes treatment, a decrease of obesity etc. However, many drugs have been tested for the nonalcoholic steatohepatitis treatment only a few drugs such as vitamin E and pioglitazone showed a positive effect. Other drugs such as ursodeoxycholic acid, metformin, statins, orlistat and pentoxifylline showed only partially positive results.The major elements that can be considered for the pathological protagonists of nonalcoholic steatohepatitis are oxidative stress, altered lipid metabolism adipose and pancreas tissues, bile acids, gut microbiota, bacterial endotoxins, and systemic chronic inflammation.
This report contains market size and forecasts of Nonalcoholic Steatohepatitis Treatment in global, including the following market information:
Global Nonalcoholic Steatohepatitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nonalcoholic Steatohepatitis Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nonalcoholic Steatohepatitis Treatment companies in 2021 (%)
The global Nonalcoholic Steatohepatitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nonalcoholic Steatohepatitis Treatment include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals and Galectin Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nonalcoholic Steatohepatitis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonalcoholic Steatohepatitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Type, 2021 (%)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Application, 2021 (%)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Nonalcoholic Steatohepatitis Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nonalcoholic Steatohepatitis Treatment revenues share in global market, 2021 (%)
Key companies Nonalcoholic Steatohepatitis Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nonalcoholic Steatohepatitis Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Nonalcoholic Steatohepatitis Treatment in global, including the following market information:
Global Nonalcoholic Steatohepatitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nonalcoholic Steatohepatitis Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nonalcoholic Steatohepatitis Treatment companies in 2021 (%)
The global Nonalcoholic Steatohepatitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nonalcoholic Steatohepatitis Treatment include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals and Galectin Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nonalcoholic Steatohepatitis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonalcoholic Steatohepatitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Type, 2021 (%)
- Solid
- Liquid
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Diagnostic Center
- Specialized Clinic
- Hospital Pharmacy
- Drug Store
- Mail Order Pharmacy
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Nonalcoholic Steatohepatitis Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nonalcoholic Steatohepatitis Treatment revenues share in global market, 2021 (%)
Key companies Nonalcoholic Steatohepatitis Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nonalcoholic Steatohepatitis Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AstraZeneca
- Arena Pharmaceuticals
- GSK
- Novo Nordisk
- Roche
- Vivus
- Arisaph Pharmaceuticals
- Cempra Pharmaceuticals
- Galectin Therapeutics
- Galmed Pharmaceuticals
- Genfit
- Gilead
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Nonalcoholic Steatohepatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonalcoholic Steatohepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NONALCOHOLIC STEATOHEPATITIS TREATMENT OVERALL MARKET SIZE
2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size: 2021 VS 2028
2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Nonalcoholic Steatohepatitis Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Nonalcoholic Steatohepatitis Treatment Players in Global Market
3.2 Top Global Nonalcoholic Steatohepatitis Treatment Companies Ranked by Revenue
3.3 Global Nonalcoholic Steatohepatitis Treatment Revenue by Companies
3.4 Global Nonalcoholic Steatohepatitis Treatment Sales by Companies
3.5 Global Nonalcoholic Steatohepatitis Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Nonalcoholic Steatohepatitis Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Nonalcoholic Steatohepatitis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Market Size Markets, 2021 & 2028
4.1.2 Solid
4.1.3 Liquid
4.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2022
4.2.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2023-2028
4.2.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
4.3.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales, 2017-2022
4.3.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales, 2023-2028
4.3.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Nonalcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Specialized Clinic
5.1.5 Hospital Pharmacy
5.1.6 Drug Store
5.1.7 Mail Order Pharmacy
5.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2022
5.2.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2023-2028
5.2.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
5.3.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales, 2017-2022
5.3.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales, 2023-2028
5.3.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Nonalcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2022
6.2.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2023-2028
6.2.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
6.3.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales, 2017-2022
6.3.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales, 2023-2028
6.3.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.4.2 By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.4.3 US Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.4.4 Canada Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.4.5 Mexico Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.5.3 Germany Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.4 France Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.5 U.K. Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.6 Italy Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.7 Russia Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.9 Benelux Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.6.3 China Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.4 Japan Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.5 South Korea Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.7 India Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.7.2 By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.7.3 Brazil Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.7.4 Argentina Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.8.3 Turkey Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8.4 Israel Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8.6 UAE Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.1.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Corporate Summary
7.2.2 Arena Pharmaceuticals Business Overview
7.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Arena Pharmaceuticals Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.3.4 GSK Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.4.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.5.4 Roche Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Roche Key News
7.6 Vivus
7.6.1 Vivus Corporate Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.6.4 Vivus Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Vivus Key News
7.7 Arisaph Pharmaceuticals
7.7.1 Arisaph Pharmaceuticals Corporate Summary
7.7.2 Arisaph Pharmaceuticals Business Overview
7.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Arisaph Pharmaceuticals Key News
7.8 Cempra Pharmaceuticals
7.8.1 Cempra Pharmaceuticals Corporate Summary
7.8.2 Cempra Pharmaceuticals Business Overview
7.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Cempra Pharmaceuticals Key News
7.9 Galectin Therapeutics
7.9.1 Galectin Therapeutics Corporate Summary
7.9.2 Galectin Therapeutics Business Overview
7.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Galectin Therapeutics Key News
7.10 Galmed Pharmaceuticals
7.10.1 Galmed Pharmaceuticals Corporate Summary
7.10.2 Galmed Pharmaceuticals Business Overview
7.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Galmed Pharmaceuticals Key News
7.11 Genfit
7.11.1 Genfit Corporate Summary
7.11.2 Genfit Nonalcoholic Steatohepatitis Treatment Business Overview
7.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.11.4 Genfit Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Genfit Key News
7.12 Gilead
7.12.1 Gilead Corporate Summary
7.12.2 Gilead Nonalcoholic Steatohepatitis Treatment Business Overview
7.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.12.4 Gilead Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Gilead Key News
8 GLOBAL NONALCOHOLIC STEATOHEPATITIS TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nonalcoholic Steatohepatitis Treatment Production Capacity, 2017-2028
8.2 Nonalcoholic Steatohepatitis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Nonalcoholic Steatohepatitis Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NONALCOHOLIC STEATOHEPATITIS TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Nonalcoholic Steatohepatitis Treatment Industry Value Chain
10.2 Nonalcoholic Steatohepatitis Treatment Upstream Market
10.3 Nonalcoholic Steatohepatitis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nonalcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Nonalcoholic Steatohepatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonalcoholic Steatohepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NONALCOHOLIC STEATOHEPATITIS TREATMENT OVERALL MARKET SIZE
2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size: 2021 VS 2028
2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Nonalcoholic Steatohepatitis Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Nonalcoholic Steatohepatitis Treatment Players in Global Market
3.2 Top Global Nonalcoholic Steatohepatitis Treatment Companies Ranked by Revenue
3.3 Global Nonalcoholic Steatohepatitis Treatment Revenue by Companies
3.4 Global Nonalcoholic Steatohepatitis Treatment Sales by Companies
3.5 Global Nonalcoholic Steatohepatitis Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Nonalcoholic Steatohepatitis Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Nonalcoholic Steatohepatitis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Market Size Markets, 2021 & 2028
4.1.2 Solid
4.1.3 Liquid
4.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2022
4.2.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2023-2028
4.2.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
4.3.1 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales, 2017-2022
4.3.2 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales, 2023-2028
4.3.3 By Type - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Nonalcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Specialized Clinic
5.1.5 Hospital Pharmacy
5.1.6 Drug Store
5.1.7 Mail Order Pharmacy
5.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2022
5.2.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2023-2028
5.2.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
5.3.1 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales, 2017-2022
5.3.2 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales, 2023-2028
5.3.3 By Application - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Nonalcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2022
6.2.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue, 2023-2028
6.2.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales & Forecasts
6.3.1 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales, 2017-2022
6.3.2 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales, 2023-2028
6.3.3 By Region - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.4.2 By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.4.3 US Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.4.4 Canada Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.4.5 Mexico Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.5.3 Germany Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.4 France Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.5 U.K. Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.6 Italy Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.7 Russia Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.5.9 Benelux Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.6.3 China Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.4 Japan Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.5 South Korea Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.6.7 India Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.7.2 By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.7.3 Brazil Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.7.4 Argentina Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, 2017-2028
6.8.3 Turkey Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8.4 Israel Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
6.8.6 UAE Nonalcoholic Steatohepatitis Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.1.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Corporate Summary
7.2.2 Arena Pharmaceuticals Business Overview
7.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Arena Pharmaceuticals Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.3.4 GSK Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.4.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.5.4 Roche Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Roche Key News
7.6 Vivus
7.6.1 Vivus Corporate Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.6.4 Vivus Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Vivus Key News
7.7 Arisaph Pharmaceuticals
7.7.1 Arisaph Pharmaceuticals Corporate Summary
7.7.2 Arisaph Pharmaceuticals Business Overview
7.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Arisaph Pharmaceuticals Key News
7.8 Cempra Pharmaceuticals
7.8.1 Cempra Pharmaceuticals Corporate Summary
7.8.2 Cempra Pharmaceuticals Business Overview
7.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Cempra Pharmaceuticals Key News
7.9 Galectin Therapeutics
7.9.1 Galectin Therapeutics Corporate Summary
7.9.2 Galectin Therapeutics Business Overview
7.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Galectin Therapeutics Key News
7.10 Galmed Pharmaceuticals
7.10.1 Galmed Pharmaceuticals Corporate Summary
7.10.2 Galmed Pharmaceuticals Business Overview
7.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Galmed Pharmaceuticals Key News
7.11 Genfit
7.11.1 Genfit Corporate Summary
7.11.2 Genfit Nonalcoholic Steatohepatitis Treatment Business Overview
7.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.11.4 Genfit Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Genfit Key News
7.12 Gilead
7.12.1 Gilead Corporate Summary
7.12.2 Gilead Nonalcoholic Steatohepatitis Treatment Business Overview
7.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Major Product Offerings
7.12.4 Gilead Nonalcoholic Steatohepatitis Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Gilead Key News
8 GLOBAL NONALCOHOLIC STEATOHEPATITIS TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nonalcoholic Steatohepatitis Treatment Production Capacity, 2017-2028
8.2 Nonalcoholic Steatohepatitis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Nonalcoholic Steatohepatitis Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NONALCOHOLIC STEATOHEPATITIS TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Nonalcoholic Steatohepatitis Treatment Industry Value Chain
10.2 Nonalcoholic Steatohepatitis Treatment Upstream Market
10.3 Nonalcoholic Steatohepatitis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nonalcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Nonalcoholic Steatohepatitis Treatment in Global Market
Table 2. Top Nonalcoholic Steatohepatitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Nonalcoholic Steatohepatitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Nonalcoholic Steatohepatitis Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type
Table 9. List of Global Tier 1 Nonalcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 46. AstraZeneca Corporate Summary
Table 47. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 48. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Arena Pharmaceuticals Corporate Summary
Table 50. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 51. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 54. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Novo Nordisk Corporate Summary
Table 56. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 57. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Roche Corporate Summary
Table 59. Roche Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 60. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Vivus Corporate Summary
Table 62. Vivus Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 63. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Arisaph Pharmaceuticals Corporate Summary
Table 65. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 66. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Cempra Pharmaceuticals Corporate Summary
Table 68. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 69. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Galectin Therapeutics Corporate Summary
Table 71. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 72. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Galmed Pharmaceuticals Corporate Summary
Table 74. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 75. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Genfit Corporate Summary
Table 77. Genfit Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 78. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Gilead Corporate Summary
Table 80. Gilead Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 81. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Nonalcoholic Steatohepatitis Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Nonalcoholic Steatohepatitis Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Nonalcoholic Steatohepatitis Treatment Production by Region, 2017-2022 (K Units)
Table 85. Global Nonalcoholic Steatohepatitis Treatment Production by Region, 2023-2028 (K Units)
Table 86. Nonalcoholic Steatohepatitis Treatment Market Opportunities & Trends in Global Market
Table 87. Nonalcoholic Steatohepatitis Treatment Market Drivers in Global Market
Table 88. Nonalcoholic Steatohepatitis Treatment Market Restraints in Global Market
Table 89. Nonalcoholic Steatohepatitis Treatment Raw Materials
Table 90. Nonalcoholic Steatohepatitis Treatment Raw Materials Suppliers in Global Market
Table 91. Typical Nonalcoholic Steatohepatitis Treatment Downstream
Table 92. Nonalcoholic Steatohepatitis Treatment Downstream Clients in Global Market
Table 93. Nonalcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global Market
Table 1. Key Players of Nonalcoholic Steatohepatitis Treatment in Global Market
Table 2. Top Nonalcoholic Steatohepatitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Nonalcoholic Steatohepatitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Nonalcoholic Steatohepatitis Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type
Table 9. List of Global Tier 1 Nonalcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales, (K Units), 2023-2028
Table 46. AstraZeneca Corporate Summary
Table 47. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 48. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Arena Pharmaceuticals Corporate Summary
Table 50. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 51. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 54. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Novo Nordisk Corporate Summary
Table 56. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 57. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Roche Corporate Summary
Table 59. Roche Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 60. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Vivus Corporate Summary
Table 62. Vivus Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 63. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Arisaph Pharmaceuticals Corporate Summary
Table 65. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 66. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Cempra Pharmaceuticals Corporate Summary
Table 68. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 69. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Galectin Therapeutics Corporate Summary
Table 71. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 72. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Galmed Pharmaceuticals Corporate Summary
Table 74. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 75. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Genfit Corporate Summary
Table 77. Genfit Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 78. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Gilead Corporate Summary
Table 80. Gilead Nonalcoholic Steatohepatitis Treatment Product Offerings
Table 81. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Nonalcoholic Steatohepatitis Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Nonalcoholic Steatohepatitis Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Nonalcoholic Steatohepatitis Treatment Production by Region, 2017-2022 (K Units)
Table 85. Global Nonalcoholic Steatohepatitis Treatment Production by Region, 2023-2028 (K Units)
Table 86. Nonalcoholic Steatohepatitis Treatment Market Opportunities & Trends in Global Market
Table 87. Nonalcoholic Steatohepatitis Treatment Market Drivers in Global Market
Table 88. Nonalcoholic Steatohepatitis Treatment Market Restraints in Global Market
Table 89. Nonalcoholic Steatohepatitis Treatment Raw Materials
Table 90. Nonalcoholic Steatohepatitis Treatment Raw Materials Suppliers in Global Market
Table 91. Typical Nonalcoholic Steatohepatitis Treatment Downstream
Table 92. Nonalcoholic Steatohepatitis Treatment Downstream Clients in Global Market
Table 93. Nonalcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Nonalcoholic Steatohepatitis Treatment Segment by Type
Figure 2. Nonalcoholic Steatohepatitis Treatment Segment by Application
Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nonalcoholic Steatohepatitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Nonalcoholic Steatohepatitis Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nonalcoholic Steatohepatitis Treatment Revenue in 2021
Figure 9. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 19. US Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 24. Germany Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 33. China Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Nonalcoholic Steatohepatitis Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Nonalcoholic Steatohepatitis Treatment by Region, 2021 VS 2028
Figure 50. Nonalcoholic Steatohepatitis Treatment Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Nonalcoholic Steatohepatitis Treatment Segment by Type
Figure 2. Nonalcoholic Steatohepatitis Treatment Segment by Application
Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nonalcoholic Steatohepatitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nonalcoholic Steatohepatitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Nonalcoholic Steatohepatitis Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nonalcoholic Steatohepatitis Treatment Revenue in 2021
Figure 9. By Type - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 19. US Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 24. Germany Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 33. China Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Nonalcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Nonalcoholic Steatohepatitis Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Nonalcoholic Steatohepatitis Treatment by Region, 2021 VS 2028
Figure 50. Nonalcoholic Steatohepatitis Treatment Industry Value Chain
Figure 51. Marketing Channels
